Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression

International Journal of Geriatric Psychiatry

Volumn 24, Issue 10, 2009, Pages 1087-1093

  Keaton, Daniel ^a,b   Lamkin, Nathan ^a,b   Cassidy, Kristin A ^a,b   Meyer, William J ^a,b   Ignacio, Rosalinda V ^c   Aulakh, Lakyntiew ^d   Blow, Frederic C ^c   Sajatovic, Martha ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d Regional Hospital   (Canada)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative medicine; Bipolar disorder; Complementary medicine; Depression; Geriatrics; Herbal compounds; Mood disorders; Nutritional supplements

Indexed keywords

HERBACEOUS AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; GERONTOPSYCHIATRY; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; SELF REPORT;

AGED; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PHYTOTHERAPY; PLANT PREPARATIONS; QUESTIONNAIRES;

EID: 70350738645     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2227     Document Type: Article

References (30)

1. Alderman CP, Kiepfer B. 2003. Complementary medicine use by psychiatry patients of an Australian hospital. Ann Pharmacother 37(12): 1779-1780. (Pubitemid 37466570)
2. Ananth J. 2004. Antipsychotic polypharmacy. Curr Pharm 10(18): 2231-2238.
3. Andreescu C, Mulsant BH, Emanuel JE. 2008. Complementary and alternative medicine in the treatment of bipolar disorder-a review of the evidence. J Affect Disord, 110(1-2): 16-26.
4. Cannon KT, Choi MM, Zuniga MA. 2006. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 4(2): 134-143.
5. Cohen RJ, Ek K, Pan CS. 2002. Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation. J Gerontol A Biol Sci Med Sci 57(4): M223-M227. (Pubitemid 34263299)
6. Edie CF, Dewan N. 2005. Which psychotropics interact with four common supplements. Curr Psychiatry 4(1): 17-30.
7. Endicott J, Spitzer RL, Fleiss JL, Cohen J. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33(6): 766-7771.
8. Ernst E. 2002. The risk-benefit profile of commonly used herbal therapies: Gingko, St. John's wort, Ginseng, Echinacea, Saw palmetto, and Kava. Annals Intern Med 136: 42-53.
9. Folstein MF, Folstein SF, McHugh PR. 1975. 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198.
10. Fuller M, Sajatovic M(eds). 2007. Drug Information Handbook for Psychiatry, 6th ed. Lexi-Comp., Inc.: Cleveland, OH.
11. Grzywacz JG, Suerken CK, Quandt SA, et al. 2006. Older adults use of complementary and alternative medicine for mental health: findings from the 2002 National Health Interview Survey. J Altern Complement Med 12(5): 467-473. (Pubitemid 44061504)
12. Guy W. 1976. Clinical Global Impressions. ECDEU Assessment Manual for psychopharmacology. Publication No. (ADM). US Department of Health, Education, and Welfare (DHEW): Rockville, MD; 76-338.
13. Hayes BD. 2007. Polypharmacy and the geriatric patient. Clin Geriatr Med 23(2): 371-390.
14. Izzo AA. 2004. Drug interactions with St. John's wort (Hypericum perforatum): a review of the clinical evidence. Int J Clin Pharacol Ther 42(3): 139-148. (Pubitemid 38647590)
15. Jorm AF, Christensen H, Griffiths KM, Rodgers B. 2002. Effectiveness of complementary and self-help treatments for depression. Med J Aust 176 (Suppl): S84-S96. (Pubitemid 34575453)
16. Kales HC, Blow FC,Welsh DE, Mellow AM. 2004. Herbal products and other supplements: use by elderly veterans with depression and dementia and their caregivers. J Geriatr Psychiatry Neurol 17(1): 25-31.
17. Kaufman DW, Kelly JP, Rosenberg L, et al. 2002. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 287: 337-344. (Pubitemid 34251967)
18. Kennedy J. 2005. Herb and supplement use in the US adult population. Clin Ther 27(11): 1847-1858. (Pubitemid 41815236)
19. Kessler RC, Soukup J, Davis RB, et al. 2001. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158(2): 289-294. (Pubitemid 32116527)
20. Kreyenbuhl JA. 2007. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv 58(4): 489-495.
21. Linde K, Berner M, Egger M, Mulrow C. 2005. St. John's wort for depression: meta-analysis of randomized controlled trials. Br J Psychiatry 186: 99-107. (Pubitemid 40193777)
22. Matthews JM, Etheridge AS, Black SR. 2002. Inhibition of human cytochrome P450 activities by kava extract and kava lactones. Drug Metab Dispos 30: 1153-1157. (Pubitemid 35265819)
23. Meeks TW, Wetherell JL, Irwin MR, et al. 2007. Complementary and alternative treatments for late-life depression, anxiety and sleep disturbance: a review of randomized controlled trials. J Clinical Psychiatry 68(10): 1461-1471.
24. Morrato EH. 2007. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther 29(1): 183-195.
25. Pittler MH, Ernst E. 2000. Efficacy of kava extract for treating anxiety; systematic review and meta-analysis. J Clin Psychopharacol 20: 84-89. (Pubitemid 30056358)
26. Plushner SL. 2000. Valeriana officinalis. Am J Health-Syst Pharm 57: 328-335.
27. Russinova Z,Wewiorski NJ, Cash D. 2002. Use of alternative health care practices by persons with serious mental illness: Perceived benefits. Am J Public Health 92(10): 1600-1603.
28. Shibayama Y, Ikeda R, Motoya T, Yamada K. 2004. St. John's wort (Hypericum performatum) induces over expression of multidrug resistance protein 2(MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol 42(6): 995-1002.
29. Tachil AF, Mohan R, Bhugra D. 2007. The evidence base of complementary and alternative therapies in depression. J Affect Disord 97(1-3): 23-35. (Pubitemid 44963511)
30. Unutzer J, Klap R, Sturm R, et al. 2000. Mental disorder and the use of alternative medicine: results from a national survey. Am J Psychiatry 157(11): 1851-1857. (Pubitemid 30813144)